NL-OMON35995招募中不适用
Potential optimalisation of (Expediency) and Effectiveness of TNF-blockers - POET
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosis Rheumatoid Arthritis according to the 1987 ACR criteria
- •Treated for at least 1 year with a TNF-blocker and stable (no dose changes) DMARD treatment for the preceding 6 months
- •Low disease activity for at least 6 months, according to both patient and rheumatologist, and a DAS28<3.2 measured at at least two different time points
- •Signed informed consent.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Potential Optimalisation of (Expediency) and Effectiveness of TNF-blockers.Rheumatoid ArthritisNL-OMON22466VR1,000
招募中
不适用
The OPTIMAL study: Optimizing Performance of afiniTor by splitting Intake Moments and decreasing Adverse events whilst maintaining outcome quaLity.HER-2 negativeHormone Positieve10006291Breast CancerNL-OMON41877Antoni van Leeuwenhoek Ziekenhuis10
已完成
不适用
Prospective evaluation of determining the most effective contact for tremor control in patients with deep brain stimulation based on individual tractographyESSENTIAL TREMORParkinson's DiseaseDRKS00026596niversität zu KölnZentrum für Klinische Studien40
已完成
3 期
A clinical trial to determine the optimum dose of radioiodine for treating the left over Thyroid cancer cells after surgeryCTRI/2011/12/002291All India Institute of Medical Sciences422
进行中（未招募）
不适用
Preventing tooth decay in children in a remote community in Australia.Dental CariesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonPublic Health - EpidemiologyACTRN12615000693527Griffith University600